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Glycogen synthase kinase 3 (GSK3) inhibits signaling pathways that are essential for bone development. To study the requirement for
GSK activity during endochondral bone development, we inhibited GSK3 in cultured metatarsal bones with pharmacological antagonists.
Interestingly, we find that inhibition of GSK3 strongly repressed chondrocyte and perichondrial osteoblast differentiation. Moreover,
chondrocyte proliferation was inhibited, whereas perichondrial cell proliferation was stimulated. These results mirror the effects of fibroblast
growth factor signaling (FGF), suggesting the FGF expression is induced. Indeed, we showed that (1) FGF18 expression is stimulated
following inhibition of GSK3 and (2) GSK3 regulates FGF18 expression through the control of h-catenin levels. Stimulation of cultured
metatarsal with FGF18 had similar effects on the differentiation and proliferation of chondrocytes and perichondrial cells as GSK3
repression. This suggests that the regulation of FGF18 expression is a major function of GSK3 during endochondral bone development.
Consistent with this, we showed that the effect of GSK3 inhibition on chondrocyte proliferation is repressed in tissues lacking a receptor for
FGF18, FGF receptor 3.
D 2005 Elsevier Inc. All rights reserved.Keywords: Glycogen synthase kinase; FGF18; Bone; Cartilage; Chondrocyte; h-cateninIntroduction
Endochondral bone formation is an exquisitely controlled
process requiring both chondrocyte and osteoblast differ-
entiation. During this process, chondrocytes sequentially
differentiate through a series of stages to eventually become
hypertrophic chondrocytes. Cells in the surrounding peri-
chondrium differentiate in step with the chondrocytes and
eventually form osteoblasts, which secrete a collar of bone
around the chondrocytes (Ballock and O’Keefe, 2003;
Kronenberg, 2003; van der Eerden et al., 2003). The
molecular events that control endochondral bone develop-
ment are incompletely understood. However, genetic and
biochemical studies have defined certain signaling and
transcriptional pathways as essential for endochondral0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: naski@uthscsa.edu (M.C. Naski).development. For example, Indian hedgehog is vital for
chondrocyte and osteoblast differentiation (Lanske et al.,
1996; St-Jacques et al., 1999; Vortkamp et al., 1996). Also,
the transcription factor nuclear factor of activated T-cells
(NFAT) performs important functions during cartilage gene
expression and the differentiation of chondrocyte precursors
(Tomita et al., 2002). Additionally, canonical Wnt signaling
through h-catenin is required for normal chondrocyte and
osteoblast differentiation (Akiyama et al., 2004; Guo et al.,
2004; Hu et al., 2005). Significantly, each of these disparate
pathways is regulated by a common kinase, glycogen
synthase kinase 3 (GSK3).
GSK3 is a ubiquitously expressed kinase that regulates
diverse cellular processes ranging from metabolism to cell
fate specification (Cohen and Frame, 2001). Though first
described as the kinase that regulates glycogen synthesis
(Hemmings et al., 1981), GSK3 is now recognized to
regulate developmental pathways including Wnt and hedge-
hog signaling pathways. Hedgehog signals through the85 (2005) 496 – 507
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activity of the transcription factor cubitus interruptus (Gli
is the vertebrate ortholog). GSK3 inhibits hedgehog signal-
ing by phosphorylating cubitus interruptus, thereby induc-
ing conversion to a transcriptional repressor (Jia et al., 2002;
Price and Kalderon, 2002). GSK3 also inhibits the tran-
scription factor NFAT. Phosphorylation of the amino-
terminal regulatory domain by GSK3 results in nuclear
export of NFAT (Okamura et al., 2000), thereby inhibiting
transcriptional activity. Wnt signaling is antagonized by
GSK3 through phosphorylation of h-catenin. h-catenin
phosphorylation results in ubiquitin-dependent degradation
through the proteosome. Because each of these signaling
cascades is essential for bone and cartilage differentiation,
we hypothesize that GSK3 activity must be tightly regulated
during endochondral bone development.
Unlike many kinases, GSK3 is constitutively active.
Additionally, while many kinases are activated following
stimulus-dependent phosphorylation, GSK3 is inactivated
following phosphorylation. Several kinases including PKA,
p70S6 kinase, AKT and others catalyze phosphorylation of
a serine residue near the amino-terminus of GSK3 (Cross et
al., 1995; Fang et al., 2000; Stambolic and Woodgett, 1994).
This phosphoserine then binds to the active site and strongly
inhibits GSK3 (Frame et al., 2001). Wnt signaling through
disheveled also inhibits GSK3, although the mechanism of
inhibition is not entirely clear. Therefore, a large number of
signaling pathways and extracellular ligands all inhibit the
activity of GSK3. Because GSK3 is a constitutive kinase
that is exclusively regulated through repressor pathways, we
reasoned that we could best understand the function of
GSK3 in endochondral development by repressing GSK3
activity. To investigate the requirement for GSK activity
during endochondral bone development, we used the phar-
macological antagonists of GSK3, lithium and SB216763
(Coghlan et al., 2000; Stambolic et al., 1996). We find that
GSK3 activity is essential for endochondral bone develop-
ment. Inhibition of GSK3 with SB216763 repressed chon-
drocyte and osteoblast differentiation in cultured metatarsals
from mouse embryo. Significantly, GSK3 repression indu-
ces fibroblast growth factor 18 (FGF18) expression and in
turn, FGF18 repressed chondrocyte and osteoblast differ-
entiation. These results suggest a pathway whereby GSK
regulates endochondral bone development through the
control of FGF18 expression. In support of this, we showed
that effects on GSK3 on chondrocyte proliferation are
absent in metatarsal lacking the FGF18 receptor, fibroblast
growth factor receptor 3.Materials and methods
Reagents
Reagents were purchased from suppliers as follows:
SB216763 from Tocris (Cookson, MO); lithium chloridefrom Sigma (St. Louis, MO); FGF18 Peprotech (Rocky
Hill, NJ).
Metatarsal cultures
Metatarsals were dissected from 15.5 day C57Bl/6 or
FGF receptor 3 null embryos and cultured in serum free
alpha MEM (Invitrogen) containing with 0.005 mg/ml
ascorbic acid, 0.3 mg/ml l-glutamine, 0.05 mg/ml genta-
micin, 1 mM h-glycerophosphate and 0.2% bovine serum
albumin. The genotyping of FGF receptor 3 mice was done
as previously described (Colvin et al., 1996). Tissue
explants were grown at 37-C in a humidified 5% CO2
incubator. To ensure that comparison was made between
samples with equivalent states of differentiation, the tissues
were maintained as right and left pairs from a given embryo
and cultured in neighboring wells of a 24 well cluster plate.
All comparisons were made using matched pairs. For
histological analyses, the samples were paraffin embedded
following fixation in 4% buffered paraformaldehyde for 1 h
at room temperature.
Cell culture and transfection
MC3T3E1 (clone 4; Wang et al., 1999) was obtained from
the ATCC (Manassas, VA), cultured in a-MEM containing
10% fetal bovine serum (Hyclone), 2 mM l-glutamine,
penicillin G (100 units/ml) and streptomycin (100 Ag/ml)
at 37-C in a humidified 5% CO2 incubator. All cells were
transfected in triplicate using a modified calcium phosphate
precipitate and assayed for luciferase or h-galactosidase
activity as previously described (McEwen et al., 1999;
Reinhold et al., 2004b). The FGF18 luciferase plasmid
contained a 3.4 kb MscI fragment of the mouse FGF18
gene (extending from approximately 3.3 kb relative to
the transcriptional start site) cloned into pGL3basic
(Promega).
Immunofluorescence
4 Am paraffin sections were warmed to 70-C for 10 min,
then deparafinized and re-hydrated with a graded alcohol
series. Antigen retrieval was done for 20 min in 10 mM pH
6.0 citrate buffer heated to 95-C prior to immersion of the
slides. Thereafter, the slides were washed with phosphate
buffered saline (PBS) and blocked in 1% fraction-V heat
shock treated bovine serum albumin (Fisher), 5% normal
goat or rabbit serum (Jackson ImmunoResearch Laborato-
ries), 0.1% Triton X-100, in PBS. After 1 h, the blocking
buffer was removed and replaced with 50 Al of blocking
buffer containing the primary antibody (h-catenin Santa
Cruz, sc7963 or N-cadherin, Transduction Labs, 610920) at
a 1:200 dilution. Slides remained in the humidified
chamber and incubated at 4-C overnight. The slides were
washed three times with PBS containing 0.1% TX-100 and
then blocked for 1 h at room temperature. Secondary
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ImmunoResearch Laboratories) for 1 h at room temperature
at a 1:800 dilution. The samples were washed three times in
PBS and mounted with Pro-Long Anti-fade reagent
(Molecular Probes). Images were obtained with a Zeiss
Axioscope 2 fitted with 40 (NA 1.3) and 63 (NA 1.4)
objectives. Deconvolution was done using Zeiss Axiovision
software.
BrdU labeling
Tissues were pulse-labeled with 10 AM 5-bromo-2-
deoxyuridine (Sigma) for 3 h. Tissues were then washed
with PBS, paraffin embedded and sectioned to 4 Am.
Slides were deparafinized, hydrated and immersed for 30
min in PBS containing 10% methanol and 3% hydrogen
peroxide. After washing with PBS, the tissues were
digested with 400 Ag/ml pepsin (Sigma) containing 0.01
N HCl for 30 min at room temperature, neutralized for 10
min in 0.1 M borate pH 8.5, then rinsed with PBS. BrdU
was detected with the Vectastain ABC kit (Vector Labs
PK-4002) according to the manufacturer’s protocol usingan anti-BrdU antibody (Sigma B-2531). The labeling
index was calculated by counting the number of BrdU-
labeled nuclei and divided by the total number of cells
within a grid drawn using Photoshop (Adobe). Equal
areas of chondrocytes were counted in the control and
treatment groups. For perichondrial cells, the entire
perichondrium was counted. P values were determined
using a paired Student’s t test. The null hypothesis was
rejected for P < 0.05.
Real time quantitative PCR
Total RNA was extracted by homogenizing metatarsals
using RNA-Bee (Tel-Test, Inc.) according to the manufac-
turer’s protocol. One microgram of RNA was reverse
transcribed in 25 Al at 42-C for 2 h using TaqMan reverse
transcription reagents with random hexamers according to
manufacturer directions (Applied Biosystems). Quantitative
PCR was performed in the ABI Prism 7000 Sequence
Detection System according to manufacturer’s directions
(Applied Biosystems). 25 Al PCR reactions were made of
SYBR Green 2 PCR Master Mix (Applied Biosystems), 5
Fig. 1. Endochondral bone development in cultured mouse metatarsals. (A) 15.5 day mouse embryo metatarsals undergo development in culture. Left panel
shows the tissue at the beginning of the culture period. Middle panel after 4 days in culture. Left panel shows that indirect immunofluorescence for N-cadherin
identifies mature osteoblasts at sites of bone formation. Osteoblasts joined by N-cadherin containing adherens junctions develop in concert with chondrocyte
hypertrophy. The figure shows the pseudocolored (red) fluorescence signal for N-cadherin overlaid on DIC images. (B) Control samples show the domain of
chondrocyte hypertrophy and arrowheads indicate the osteoid bone collar. Right and left panels were obtained with 10 or 20 objectives, respectively. (C)
Treatment of metatarsal cultures for 48 h with 15 mM lithium chloride repressed chondrocyte hypertrophy. Right and left panels were obtained with 10 or
20 objectives, respectively. (D) Chondrocyte hypertrophy is absent in metatarsal cultures treated for 48 h with 20 AM SB216763. Also note the absence of a
bone collar. (E) In situ hybridization for collagen type X. Pseudo-colored (green) dark-field images are overlaid bright field images to show repressed
chondrocyte hypertrophy in the sample treated with 15 mM lithium chloride. (F) Inhibition of GSK3 represses osteoblast differentiation. Indirect
immunofluorescence for N-cadherin highlights osteoblasts at the site of bone collar synthesis adjacent to hypertrophic chondrocytes. N-cadherin linked
osteoblasts are absent in the sample treated with 20 AM SB216763. The figure shows the pseudocolored (red) fluorescence signal overlaid on DIC images. (G)
In situ hybridization for collagen type I. Pseudo-colored (green) dark-field images are overlaid bright field images to show repressed osteoblast differentiation
in the sample treated with 20 AM SB216763. The figures show representative results from 4 independent experiments.
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Cycling conditions were 50-C for 2 min, 95-C for 10 min
followed by 40 cycles of 15 s at 95-C and 60 s at 60-C.
Primers were designed using PrimerExpress (Applied Bio-
systems). Oligonucleotides used were as follows: FGF1- 5V-
CGGCTCGCAGACACCAA-3V, 5V-ACCAGTTCTTCTCC-
GCATGCT-3V; FGF2- 5V-GGACCCCAAGCGGCTCTA-3V,
5V-CCTCTCTCTTCTGCTTGGAGTTGT-3V; FGF3- 5V-
GTGAACGGCAGCCTTGAGA-3V, 5V-CAGGTACCGC-
CCAGAAAAGA-3V; FGF4- 5V-CGAGGCGTGGTGAGC-
ATCT-3V, 5V-CGTTGTAGTTGTTGGGCAGAAGT-3V;
FGF7- 5V-TGAAGAACAGCTACAACATCATGGA-3V, 5V-
TCAGTTCTTTGAAGTTGCAATCCT-3V; FGF8- 5V-CTC-ATTGTGGAGACCGATACTTTTG-3V, 5V-GCCGTTGCT-
CTTGGCAATT-3V; FGF9- 5V-ATCTTCCCCAACGGTAQ
CTATCCA-3V; 5V-CTCGTTCATGCCGAGGTAGAGT-3V;
FGF10- 5V-AGTGCGGGAAGGCATGTG-3V, 5V-CTCCGA-
TTTCCACTGATGTTATCTC-3V; FGF11- 5V-TCCTTCAC-
CCACTTCAATCTGA-3V, 5V-TGAAATGTGGCGAGCTGQ
TACA-3V; FGF12- 5V-AACCCCAGCTGAAAGGGATT-3V,
5V-GCCACCACACGCAGTCCTA-3V; FGF13- 5V-AGGAGA-
CCAGAGCCTCAGCTT-3V, 5V-CGTCTTTGGTGCCATC-
AATG-3V; FGF14- 5V-GCTCTCGATGGAACCAAGGA-3V,
5V-TTGCTATGTACAACCCTGTCTTCAC-3V; FGF18- 5V-
ACTGCTGTGCTTCCAGGTTC-3V, 5V-CCCAGGACTTG-
AATGTGCTT-3V; FGF20- 5V-GGATCACAGTCTCTTCGG-
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FGF22- 5V-CTTCTCCTCCACTCACTTTTTCCT-3V; 5V-GCC-
TGAGTACACAGCTTTGATCAC-3V; aggrecan- 5V-ACTG-
CAGCGATGACCCTC-3V, 5V-GGAATCCCTAGCTGCTTCQ
G-3V; collagen II- 5V-GAAGGTGGAAAGCAAGGTGA-3V,
5V-CATCAGTACCAGGAGTGCCA-3V; conduction- 5V-AA-
AACGGATTCAGGTCCTTCAA-3V; 5V-GTCAGTGCGTC-
GCTGGATAAC-3V; Indian hedgehog- 5V-CAATCCCGAQ
CATCATCTTCA-3V; 5V-GCGGCCCTCATAGTGTAAAG-3V.
In situ hybridization
4 Am sections of paraffin embedded tissues were pro-
cessed, hybridized and washed according to the mRNA
locator protocol (Ambion). The FGF18 (gift from D. Ornitz,
St. Louis, MO) and collagen type X (B. Olson Boston, MA)
riboprobes were labeled as previously described (Naski
et al., 1998).Fig. 2. Real time RT-PCR measurement of gene expression in cultured
metatarsals. Relative expression determined by quantitative real time PCR
of the aggrecan (agg), type II collagen (col2), Indian hedgehog (Ihh),
patched (ptc) and conductin. RNA harvested from metatarsals cultured 48 h
in the presence or absence of 20 AM SB216763 was reverse transcribed
with random hexamers. Expression levels were normalized to the 18s rRNA
internal control. The expression levels for each pair are relative to each
other with the lesser sample defined as one. The results show representative
results of two independent samples.Results
To understand how GSK3 controls endochondral bone
formation, we studied the differentiation of mouse embryo
metatarsals in organ culture. This is an established method
for investigating the differentiation of chondrocytes and
osteoblasts during endochondral bone development (Die-
udonne et al., 1994; Serra et al., 1999). Mouse metatarsal
bone rudiments were prepared from 15.5 day embryos and
cultured in serum-free medium. At the time of isolation, the
bone rudiments contain immature chondrocytes surrounded
by a sheath of undifferentiated perichondrial cells (Fig. 1A).
Osteoblasts and hypertrophic chondrocytes are absent. After
3–4 days in serum-free medium, chondrocyte hypertrophy
begins (Fig. 1A). Simultaneously, cells in the perichondrium
differentiate into osteoblasts and secrete a collar of woven
bone around the hypertrophic chondrocytes. The mature
osteoblasts synthesizing the collar of bone are identified by
the presence of N-cadherin organized into adherens junc-
tions (Fig. 1A).
To investigate how GSK3 regulates endochondral bone
formation in metatarsals, we used specific pharmacological
antagonists of GSK3. GSK3 is a constitutive kinase that is
regulated through repressor pathways. Therefore, we
modeled the regulation of GSK3 using the pharmacological
inhibitors lithium and SB216763. Interestingly, endochon-
dral bone development was strikingly inhibited following
inhibition of GSK3 with either lithium or SB216763 for 48
h. This was evidenced by substantial or complete inhibition
of chondrocyte hypertrophy in the samples treated with the
GSK3 inhibitors lithium and SB216763 (Figs. 1B–D). And
is further evidenced by the repression of type X collagen
expression, a marker for hypertrophic chondrocytes (Fig.
1E). In addition to the inhibition of chondrocyte differ-
entiation, we observed a concomitant inhibition of peri-
chondrial osteoblast differentiation. This was evidenced bythe absence of a collar of woven bone surrounding the
hypertrophic chondrocytes (compare the right panels of
Figs. 1B and D), the absence of osteoblasts containing N-
cadherin organized into adherens junctions (Fig. 1F) and
dramatically reduced expression of type I collagen (Fig.
1G). Note that scattered chondrocytes contain detectable
levels of N-cadherin following treatment with SB216763.
Immature chondroblasts express N-cadherin (Oberlender
and Tuan, 1994a,b). The presence of N-cadherin in these
cells reflects the strong repression of differentiation and
immature phenotype of these cells.
To further characterize the effects of GSK3 on chon-
drocyte differentiation, we performed quantitative RT-PCR
with RNA extracted from metatarsals. Corroborating the in
situ hybridization data of Fig. 1E, inhibition of GSK3
repressed the expression of type X collagen greater than
3000-fold as measured by quantitative real time PCR (data
not shown). Also, other chondrocyte-specific genes were
inhibited. The expression of both type II collagen and
aggrecan was dramatically repressed following inhibition of
GSK3 (Fig. 2). Also, the expression of Indian hedgehog and
patched, the hedgehog receptor, was repressed in these
samples. Because patched is both a receptor and transcrip-
tional target of Indian hedgehog, these findings suggest that
hedgehog signaling was repressed. Notice that the expres-
sion of conductin, a transcriptional target of h-catenin (Jho
et al., 2002), was induced following inhibition of GSK3.
To investigate if GSK3 also regulated cell prolifer-
ation, we performed bromodeoxyuridine (BrdU) labeling
experiments. Metatarsal samples were treated with the
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BrdU for 3 h. Proliferating cells were identified by
immunostaining for BrdU. Interestingly, inhibition of
GSK3 had opposite effects on chondrocyte and perichon-
drial cell proliferation (Fig. 3). Inhibition of GSK3
repressed chondrocyte proliferation (Fig. 3B), whereas
perichondrial cell proliferation was stimulated following
inhibition of GSK3 (Fig. 3C). Significantly, these data
showing inhibition of chondrocyte differentiation and
proliferation resemble the effects of FGF signaling in
cartilage (Deng et al., 1996; Kato and Iwamoto, 1990; Li
et al., 1999; Naski et al., 1998) and are similar to results
obtained when bone explants are stimulated with FGF
(Mancilla et al., 1998).
Because these results suggest augmented FGF signaling,
we hypothesized that inhibition of GSK3 stimulates FGF
expression. To test this, we determined FGF expression by
quantitative real time PCR. Interestingly, we observed that
FGF13 and FGF18 were substantially induced following the
inhibition of GSK3 (Fig. 4A). The induction of FGF18 is
intriguing because FGF18 is an essential regulator of
endochondral bone development (Liu et al., 2002; Ohbaya-
shi et al., 2002). To further define the effects of GSK3 on
FGF expression, we performed in situ hybridization for
FGF18. Consistent with the quantitative PCR results,
FGF18 expression was induced following treatment with
the GSK3 inhibitor, SB216763 (Figs. 4B and C). Signifi-
cantly, FGF18 expression is most abundant in the perichon-
drial cells. This coincides with perichondrial regions wherein
h-catenin levels are strongly upregulated adjacent to theFig. 3. Inhibition of GSK3 inhibits chondrocyte proliferation, but augments perich
showing labeling of chondrocyte and perichondrial cells from control (left panel) o
(B) Chondrocyte proliferation after treatment with 20 AM SB216763 for 48 h a
hypothesis was rejected with P = 0.01. (C) Perichondrial cell proliferation after trea
labeled nuclei. The null hypothesis was rejected with P < 0.01. The figures showhypertrophic chondrocytes in samples without the GSK3
inhibitor (Fig. 4D). Because inhibition of GSK3 by
SB216763 results in stabilization of h-catenin (hcat) and
increased levels of hcat protein (data not shown), we
hypothesized that hcat is essential for induction of FGF18
expression. To determine if hcat regulates the transcription of
FGF18, we performed experiments using the immature
osteoblast cell line MC3T3E1. Fig. 5A shows that inhibition
of GSK3 induces FGF18 in MC3T3E1 cells. To determine if
hcat-dependent transcription is activated in response to
inhibition of GSK3, we used TOPFLASH, a luciferase
reporter requiring h-catenin/TCF for activation (Korinek et
al., 1997).We found that TOPFLASH activity is stimulated in
a dose-dependent manner by SB216763 (Fig. 5B). To
determine if the FGF18 promoter is stimulated by hcat, cells
were transfected with a luciferase reporter containing 3.4 kb
of the proximal FGF18 promoter. Significantly, the FGF18
promoter was induced when hcat-dependent activity was
stimulated by either inhibition of GSK3 with SB216763 or
co-transfection of a stabilized form of hcat (Figs. 5C and D).
These data support the conclusion that inhibition of GSK3
induces FGF18 gene expression through upregulation of hcat
levels.
We showed that inhibition of GSK3 stimulated FGF
expression and repressed chondrocyte differentiation and
proliferation. To determine if these findings may be linked,
we investigated whether the effects of FGF18 on metatarsal
rudiments phenocopy the effects of GSK3 inhibition.
Interestingly, we observed similarities between inhibition
of GSK3 and activation of FGF signaling with FGF18.ondrial cell proliferation. (A) DIC images of BrdU immunohistochemistry
r 20 AM SB216763 (right panel) treated samples following 48 h treatment.
s measured by the fraction of BrdU-labeled chondrocyte nuclei. The null
tment with 20 AM SB216763 for 48 h as measured by the fraction of BrdU-
representative results from 3 independent experiments.
Fig. 4. Inhibition of GSK3 stimulates FGF18 expression. (A) Survey of FGF expression by real time quantitative RT-PCR. Relative FGF expression using
RNA isolated from samples cultured 48 h in the presence or absence of 20 AM SB216763. FGF expression levels were normalized to the 18s rRNA internal
control. Expression levels for each pair (with or without SB216763) are relative to the control sample (defined as one). The results show representative
results of two independent samples. (B and C) In situ hybridization for FGF18 in metatarsals cultured in the presence or absence of 20 AM SB216763 for 48
h. Results show the overlay of pseudocolored (green) dark-field images on bright field images. (D) Indirect immunofluorescence of h-catenin. The
fluorescence signal for h-catenin is overlaid to the DIC image showing upregulation of beta-catenin in the perichondrial layer. Sample was cultured without
SB216763.
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drocyte proliferation and differentiation. This is demonstra-
ted by the inhibition of chondrocyte hypertrophy and
inhibition of BrdU labeling (Figs. 6A and B). Also,
perichondrial osteoblast differentiation is concomitantly
inhibited as evidenced by diminished synthesis of a collar
of woven bone (Fig. 6A), the absence of mature osteoblasts
joined by N-cadherin-containing adherens junctions (Fig.
6C) and strong repression of type I collagen expression (Fig.
6D). Also, FGF18 stimulated perichondrial cell proliferation
(Fig. 6B, right), similar to inhibition of GSK3.
These findings suggest that the repression of endochon-
dral bone development resulting from inhibition of GSK3 isin part caused by the induction of FGF expression. To better
understand the role of FGF signaling following repression
of GSK3, we performed experiments with metatarsals from
mice lacking FGF receptor 3 (FGFR3/). FGF receptor 3
is expressed in cartilage and is the major receptor for
FGF18 in cartilage. Therefore, if the induction of FGF18
contributes to the inhibition of endochondral development,
then the inhibition will be diminished in the cartilage of
FGFR3 null mice. Consistent with this, we find that in the
absence of FGFR3 chondrocyte proliferation was not
repressed when GSK3 is inhibited. Fig. 7A shows that as
observed previously chondrocyte proliferation is inhibited
when GSK3 is inhibited in heterozygous mice. However,
Fig. 5. Induction of FGF18 expression. (A) Induction of FGF18 expression in MC3T3E1 immature osteoblasts after inhibition of GSK3 with 18 AM SB216763
for the indicated times. Expression levels were determined by real time RT-PCR. (B) Activation of TOPFLASH luciferase in MC3T3E1 osteoblasts after
treatment with the indicated concentrations of SB216763 for 24 h. (C) Inhibition of GSK3 stimulates the FGF18 luciferase promoter in MC3T3E1 osteoblasts.
MC3T3E1 osteoblasts were transiently transfected with the FGF18 luciferase promoter as indicated above the panel and treated for 24 h with 20 AM SB216763.
Luciferase activity was normalized to h-galactosidase activity derived from a constitutive co-transfected plasmid. (D) h-catenin activates the FGF18 promoter.
MC3T3E1 osteoblasts were transiently transfected with the FGF18 luciferase promoter and a proteosome resistant form of hcat. Luciferase activity was
normalized to h-galactosidase activity derived from a constitutive co-transfected plasmid. Results are representative of three independent experiments.
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ation in metatarsals from FGFR3/ mice.Discussion
Our data have shown that GSK3 activity is essential for
endochondral bone development. Inhibition of GSK3 by
either lithium or SB216763 strongly inhibits chondrocyte
and perichondrial osteoblast differentiation. Because these
agents inhibit GSK3 kinase activity by different mecha-
nisms yet similarly repress endochondral bone development,
we conclude that the effects of these inhibitors are due to
specific inactivation of GSK3 (Coghlan et al., 2000; Ryves
and Harwood, 2001). The specificity of SB216763 has been
validated by evaluation of a large panel of kinases (Coghlan
et al., 2000).
Because GSK3 activity is essential for endochondral
bone development, certain substrates of GSK3 are vitalregulators of endochondral bone development. There are
many putative substrates for GSK3 (Woodgett, 2001);
however, several well-recognized substrates are central
regulators of bone development. The hedgehog signaling
pathway activates the transcription factor Gli. Recent data
show that the Drosophila ortholog of Gli, cubitus
interruptus, is phosphorylated by GSK3 and that this leads
to the repression of Gli (Jia et al., 2002; Price and
Kalderon, 2002). Because hedgehog (Indian hedgehog) is
expressed in cartilage, we would predict extra Gli activity
when GSK3 is inhibited. However, our data suggest less
rather than more Gli activity. Patched is a transcription
target of Gli (Goodrich et al., 1996) and therefore if Gli
activity is stimulated patched expression should increase
when GSK3 is inhibited. However, we showed that patched
expression is reduced, suggesting reduced rather than
increased Gli activity. Our data showing repression of Ihh
expression following treatment with the GSK3 inhibitor are
consistent with less Gli activity. Therefore, we conclude
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Fig. 7. (A) Inhibition of GSK3 does not repress proliferation of FGFR3/ chondrocytes. Metatarsals were dissected from FGFR3 heterozygous (+/) or null
(/) embryos and cultured in the presence of absence of 20 AM SB216763 for 48 h. Thereafter, the samples were pulsed with BrdU and processed for
immunohistochemistry. The null hypothesis was rejected for samples from heterozygous, but not null mice. Results are representative of two independent
experiments. (B) Working model for the regulation of FGF18 expression. Inhibition of GSK3 through canonical Wnt signaling stimulates FGF18 expression
via upregulation of h-catenin. Inhibition of GSK3 also promotes FGF18 expression by maintaining calcineurin-dependent NFAT activity. The induction of
FGF18 expression represses chondrocyte proliferation through the action of the principle fibroblast growth factor receptor of cartilage, FGFR3. Simultaneously,
perichondrial cell proliferation is stimulated following activation of fibroblast growth factor receptors 1 and 2 (FGFR1).
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GSK3 in these experiments. The inhibition Ihh expression
may contribute to the regulation of osteoblast differ-
entiation. Osteoblast differentiation is absent in Ihh/
mice (Chung et al., 2001; St-Jacques et al., 1999),
suggesting that the reduction of Ihh expression following
inhibition of GSK3 contributes to the repression of
osteoblast differentiation.
The transcription factors, nuclear factor of activated T-
cells are also GSK3 substrates that may regulate
chondrocyte differentiation, given that we previously
showed that NFAT stimulates chondrogenesis (Tomita et
al., 2002). Because phosphorylation of NFAT by GSK3
inhibits NFAT activity (Beals et al., 1997; Neal and
Clipstone, 2001), we hypothesize that NFAT activity is
augmented in metatarsals wherein GSK3 is inhibited. In
published work, we show that FGF18 expression is
induced through NFAT-dependent pathways (Reinhold et
al., 2004a). Significantly, we now show that FGF18 is
induced in response to GSK3 inhibition. This suggestsFig. 6. Effects of FGF18 on endochondral development. (A) H & E stained sectio
Effects of FGF18 on chondrocyte (left panel) and perichondrial cell (right panel)
with BrdU and then processed for immunohistochemistry. The fraction of labeled
values. (C) Repression of osteoblast differentiation after treatment with 800 ng/m
cadherin. The control samples (top) show N-cadherin immunofluorescence in cel
signal. Right panels show the pseudocolored signal overlaid to the DIC
immunofluorescence. (D) In situ hybridization for collagen type I. Pseudo-col
repressed osteoblast differentiation in the sample treated with 800 ng/ml FGF18.that NFAT may be an important substrate of GSK3 during
endochondral bone development. However, NFAT tran-
scriptional activity requires an additional calcium-depend-
ent stimulus that dephosphorylates NFATs via the protein
phosphatase calcineurin. We showed that TGFh induces
FGF18 activation through a calcium-dependent pathway
(Reinhold et al., 2004a). In addition, data showing that
TGFh represses chondrocyte differentiation during endo-
chondral ossification suggest that a TGFh family member
may be induced in metatarsal bone rudiments (Bohme et
al., 1995; Dieudonne et al., 1994; Serra et al., 1999).
Therefore, we investigated if TGFh expression is induced
by GSK3 inhibition. We did not observe changes in the
expression of TGFh1, 2 or 3 by QPCR (data not shown).
However, our analyses of RNA extracted from the entire
metatarsal may not detect a significant induction of TGFh
in a discreet population of cells. Further studies will be
required to determine if TGFh or another pathway such as
the Wnt-calcium pathway can stimulate NFAT activity in
developing endochondral bone. Interestingly, NFAT activ-ns of metatarsals treated for 48 h with 800 ng/ml FGF18 (bottom panel). (B)
proliferation. Samples were treated with 800 ng/ml FGF18 for 48 h, pulsed
nuclei was measured and the null hypothesis was rejected at the indicated P
l FGF18. Mature osteoblasts are detected by immunofluorescence for N-
ls adjacent to hypertrophic chondrocytes. Left panels show the fluorescence
image. FGF18 treated samples (bottom) lack N-cadherin signals via
ored (green) dark-field images are overlaid bright field images to show
R.M. Kapadia et al. / Developmental Biology 285 (2005) 496–507506ity can be stimulated by Wnt signaling (Saneyoshi et al.,
2002), therefore, Wnt-calcium signaling is a potential
NFAT activator.
hcat is a GSK3 substrate that also has dramatic effects on
bone and cartilage differentiation. Phosphorylation ofhcat by
GSK3 causes degradation by the proteosome. Wnt signaling
represses proteolysis of hcat by inhibiting GSK3. Therefore,
the inhibition of GSK3 by SB216763 can simulate the effects
of Wnt signaling during endochondral development. The
effects of Wnt signaling on chondrocytes are complex. Both
inhibition and stimulation of differentiation have been
observed. Forced expression of Wnt-5a in developing
chicken limbs slowed the maturation of chondrocytes as
evidenced by diminished expression of type X collagen
(Hartmann and Tabin, 2000). Similar results are obtained
when either Wnt5a orWnt5b is expressed in cartilage of mice
(Yang et al., 2003). Surprisingly, Wnt5a null mice show the
same phenotype of delayed chondrocyte differentiation as
mice overexpressing Wnt5a (Yang et al., 2003). Moreover,
Wnt 4 expression accelerates chondrocyte hypertrophy
(Hartmann and Tabin, 2000). These data show that Wnts
can both inhibit and stimulate endochondral bone develop-
ment. Forced expression of Wnt14 in chondrocytes of mice
caused small, dysplastic skeletons, joint fusions and cartilage
hypertrophy was strongly repressed (Hartmann and Tabin,
2001). Similar observations were seen when a stabilized form
of hcat was overexpressed in cartilage implying that the
inhibition of endochondral bone development is via canon-
ical Wnt signaling (Akiyama et al., 2004; Guo et al., 2004).
Surprisingly, however, cartilage-specific deletion of hcat in
chondrocytes also causes formation of a dysplastic skeleton
with joint fusions and slowed chondrocyte differentiation
(Akiyama et al., 2004; Guo et al., 2004; Hu et al., 2005).
While these data indicate that a single simple conclusion
cannot account for all effects of Wnt signaling on endochon-
dral bone development, our results support a model wherein
the upregulation of hcat levels represses chondrocyte differ-
entiation. Also, while this manuscript was under review, other
reports provided evidence for inhibitory effects of Wnt
signaling on chondrocyte differentiation (Day et al., 2005;
Hill et al., 2005). Significantly, we showed that the
expression of FGF18 is induced following inhibition of
GSK3. Moreover, we showed that FGF18 is induced through
a hcat-dependent pathway. Others have similarly found that
FGF18 is induced by hcat (Shimokawa et al., 2003). Based
on these data and our published data showing that FGF18 is
induced through calcium-dependent pathways requiring
calcineurin/NFAT activation, we propose that FGF18 is
induced via a bipartite pathway when GSK3 is repressed.
One pathway simulates canonical Wnt signaling whereby
FGF18 is induced after upregulation of hcat protein levels.
The second path stimulates FGF18 through calcineurin/
NFATactivation. This model and the effects of FGF18 on cell
proliferation in bone rudiments are summarized in Fig. 7B.
FGF18/ mice show features of advanced differ-
entiation including an enlarged hypertrophic region andincreased chondrocyte proliferation (Liu et al., 2002;
Ohbayashi et al., 2002). These results indicate that
FGF18 inhibits endochondral differentiation. This is
further evidenced by our results showing that FGF18
repressed chondrocyte and osteoblast differentiation and
inhibited chondrocyte proliferation. These data mirror the
effects on GSK3 inhibition on cultured metatarsals. Given
our data showing that FGF18 is induced following GSK3
inhibition, we conclude that GSK3 is an essential regulator
of FGF18 expression and that FGF18 is an important
downstream mediator of the effects of GSK3 in endochon-
dral bone development. We showed that FGF18 expression
is induced by hcat, suggesting that canonical Wnt signal-
ing induced FGF18. Interestingly, the induction of FGF
expression through Wnt signaling is essential at several
steps of skeletal development. For example, the anatomical
site of limb initiation is determined by a Wnt-FGF
signaling relay. Wnt2b is expressed in the intermediate
mesenchyme of the developing embryo and induces
FGF10 expression in the adjacent lateral plate mesen-
chyme. This relay determines the site for limb develop-
ment as demonstrated by ectopic limbs that result from
forced expression of Wnt2b (Kawakami et al., 2001). Later
during limb development, FGF8 is induced in response to
Wnt3 in the ectoderm of nascent limb buds (Barrow et al.,
2003; Kawakami et al., 2001). This step is critical for both
the formation and stability of the apical ectodermal ridge.
We propose that the expression of FGF18 in response to
hcat is another example of a conserved and essential relay
whereby Wnt signaling induces FGF expression during
skeletal development.Acknowledgments
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